Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Single Person × Clear all

NCT04767009 2025-04-30

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung